Ying Du
Chief Executive Officer presso ZAI LAB LIMITED
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Fondatore di Zai Lab Ltd., Hutchison MediPharma Ltd. e Zai Venture Partners, Ying Du è un imprenditore che occupa la posizione di presidente e amministratore delegato di Zai Lab Ltd. e socio generale di Zai Venture Partners (una filiale di Zai Lab Ltd.). Il dottor Du è anche nel consiglio di amministrazione di Eden Biologics, Inc. In passato la dottoressa Du ha occupato la posizione di amministratore delegato di Hutchison MediPharma Ltd., di direttore scientifico di Hutchison China MediTech Ltd., di vicepresidente esecutivo di Hutchison Whampoa (Cina) Ltd. e di Venture Partner di Sequoia Capital China Advisors (Hong Kong) Ltd. Ying Du ha ricevuto un dottorato dall'Università di Cincinnati (Ohio) e una laurea presso l'Università di Jilin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ZAI LAB LTD.
0.11% | 03/04/2024 | 1 107 972 ( 0.11% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Ying Du
| Società | Posizione | Inizio |
|---|---|---|
| ZAI LAB LIMITED | Chief Executive Officer | 01/04/2014 |
| JHL BIOTECH, INC. | Director/Board Member | 17/12/2012 |
Zai Venture Partners
 Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Founder | 01/01/2017 |
Precedenti posizioni note di Ying Du
| Società | Posizione | Fine |
|---|---|---|
Hongshan
 Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Private Equity Investor | - |
Hutchison Whampoa (China) Ltd.
 Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Corporate Officer/Principal | - |
| HUTCHMED (CHINA) LIMITED | Chief Tech/Sci/R&D Officer | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Chief Executive Officer | - |
Formazione di Ying Du
| University of Cincinnati (Ohio) | Doctorate Degree |
| Jilin University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| HUTCHMED (CHINA) LIMITED | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Aziende private | 5 |
|---|---|
Hutchison Whampoa (China) Ltd.
Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Finance |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Finance |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Zai Venture Partners
Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Finance |
- Borsa valori
- Insiders
- Ying Du
